BNTX

E812199
COVID-19 vaccine biotechnology company mRNA COVID-19 vaccine public company stock ticker symbol

BNTX is the stock ticker symbol for BioNTech SE, a German biotechnology company known for developing mRNA-based therapies and the Pfizer–BioNTech COVID-19 vaccine.

Try in SPARQL Jump to: Surface forms Statements Referenced by

Observed surface forms (3)

Surface form Occurrences
BioNTech SE 0
Comirnaty 0
BNT162b2 0

Statements (46)

Predicate Object
instanceOf COVID-19 vaccine ⓘ
biotechnology company ⓘ
mRNA COVID-19 vaccine ⓘ
public company ⓘ
stock ticker symbol ⓘ
brandNameOf BNT162b2 NERFINISHED ⓘ
coDevelopedWith Pfizer NERFINISHED ⓘ
Pfizer NERFINISHED ⓘ
collaboratesWith Pfizer NERFINISHED ⓘ
countryOfOrigin Germany ⓘ
currency USD NERFINISHED ⓘ
developed BNT162b2 NERFINISHED ⓘ
developedBy BioNTech SE NERFINISHED ⓘ
BioNTech SE NERFINISHED ⓘ
develops antibodies ⓘ
cell therapies ⓘ
small molecule immunomodulators ⓘ
vaccines ⓘ
focusesOn immunotherapies ⓘ
infectious diseases ⓘ
mRNA-based therapies ⓘ
oncology ⓘ
foundedBy Christoph Huber NERFINISHED ⓘ
Ugur Sahin NERFINISHED ⓘ
Özlem Türeci NERFINISHED ⓘ
foundedIn 2008 ⓘ
hasCEO Ugur Sahin NERFINISHED ⓘ
hasCoFounder Christoph Huber NERFINISHED ⓘ
Özlem Türeci NERFINISHED ⓘ
hasHeadquartersLocation Mainz, Rhineland-Palatinate, Germany NERFINISHED ⓘ
hasISIN US09075V1026 ⓘ
US09075V1026 ⓘ
hasNotableProduct Comirnaty NERFINISHED ⓘ
hasStockTicker BNTX NERFINISHED ⓘ
hasTickerSymbolFor BioNTech SE NERFINISHED ⓘ
headquarteredIn Mainz, Germany NERFINISHED ⓘ
industry biotechnology ⓘ
knownFor Pfizer–BioNTech COVID-19 vaccine NERFINISHED ⓘ
legalForm Societas Europaea NERFINISHED ⓘ
listedOn NASDAQ ⓘ
NASDAQ ⓘ
primaryListingCurrency USD ⓘ
represents BioNTech SE NERFINISHED ⓘ
specializesIn mRNA technology ⓘ
personalized cancer immunotherapy ⓘ
tradedAs BNTX NERFINISHED ⓘ

Referenced by (1)

Full triples — surface form annotated when it differs from this entity's canonical label.

BioNTech → tickerSymbol → BNTX ⓘ